EUVIMEDObjevte EUVIMED
Crossref

Squalene epoxidase promotes hepatocellular carcinoma development by activating STRAP transcription and TGF‐β/SMAD signalling

Zhirui Zhang, Wei Wu, Hao Jiao, Yuzhong Chen, Xiaojun Ji, Jing Cao, Fangzhou Yin, Wu Yin

British Journal of Pharmacology · 2023-06 · 180 (12) · 1562-1581

DOI: 10.1111/bph.16024 ↗

At a glance

Journal article in British Journal of Pharmacology, published online on 2023-01-24. Written by Zhirui Zhang and 7 co-authors. Institution: The State Key Lab of Pharmaceutical Biotechnology, College of Life Sciences, Nanjing University, Nanjing, China. Major MEDLINE topics: Carcinoma, Hepatocellular, Liver Neoplasms. Cited 43 times so far (Crossref); 57 references. Funded by: National Natural Science Foundation of China, Jiangsu Provincial Key Research and Development Program, Priority Academic Program Development of Jiangsu Higher Education Institutions.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background and Purpose Squalene epoxidase (SQLE) is a key enzyme involved in cholesterol biosynthesis, but growing evidence also reveals that SQLE is abnormally expressed in some types of malignant tumours, even though the underlying mechanism remains poorly understood. Experimental Approach Bioinformatics analysis and RNA sequencing were applied to detect differentially expressed genes in clinical hepatocellular carcinoma (HCC). MTT, colony formation, AnnexinV‐FITC/PI, EdU, wound healing, transwell, western blot, qRT‐PCR, IHC, F‐actin, RNA‐sequencing, dual‐luciferase reporters, and H&E staining were used to investigate the pharmacological effects and possible mechanisms of SQLE. Key Results SQLE expression was specifically elevated in HCC, correlating with poor clinical outcomes. SQLE significantly promoted HCC growth, epithelial–mesenchymal transition, and metastasis both in vitro and in vivo. RNA sequencing and functional experiments revealed that the protumourigenic effect of SQLE on HCC was closely related to the activation of TGF‐β/SMAD signalling, but the stimulatory effect of SQLE on TGF‐β/SMAD signalling and HCC development is critically dependent on STRAP. SQLE expression is well correlated with STRAP in HCC, and further, to amplify TGF‐β/SMAD signalling, SQLE even transcriptionally increased STRAP gene expression mediated by AP‐2α. Finally, as a chemical inhibitor of SQLE, NB‐598 markedly inhibited HCC cell growth and tumour development. Conclusions and Implications Taken together, SQLE serves as a novel oncogene in HCC development by activating TGF‐β/SMAD signalling. Targeting SQLE could be useful in drug development and therapy for HCC.

Subjects

MeSH terms (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansSqualene MonooxygenaseCell LineCell ProliferationTransforming Growth Factor betaCell Line, TumorCell MovementGene Expression Regulation, Neoplastic

Author keywords

NB-598STRAPTGF-β/SMADshepatocellular carcinomasqualene epoxidase

Substances

Squalene MonooxygenaseTransforming Growth Factor beta

Authors and institutions

  • The State Key Lab of Pharmaceutical Biotechnology, College of Life Sciences, Nanjing University, Nanjing, China.
  • Organ Transplantation Center, Southern District, the First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital), Hefei, China.
  • Department of Pharmacy, Fuyang People's Hospital, Fuyang, China.
  • Department of Surgical Oncology, First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
  • Department of Innovation, Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd, Nanjing, China.
  • Department of Pharmacy, Women's Hospital of Nanjing Medical University/Nanjing Maternity and Child Health Care Hospital, Nanjing, China.

Funding

  • National Natural Science Foundation of China
  • Jiangsu Provincial Key Research and Development Program
  • Priority Academic Program Development of Jiangsu Higher Education Institutions
  • Natural Science Foundation of Jiangsu Province
  • Natural Science Foundation of Anhui Province

Cite

APA

Zhang, Z., Wu, W., Jiao, H., Chen, Y., Ji, X., Cao, J., Yin, F., & Yin, W. (2023). Squalene epoxidase promotes hepatocellular carcinoma development by activating STRAP transcription and TGF‐β/SMAD signalling. British Journal of Pharmacology, 180(12), 1562-1581. https://doi.org/10.1111/bph.16024

Vancouver

Zhang Z, Wu W, Jiao H, Chen Y, Ji X, Cao J, et al. Squalene epoxidase promotes hepatocellular carcinoma development by activating STRAP transcription and TGF‐β/SMAD signalling. British Journal of Pharmacology. 2023;180(12):1562-1581. doi:10.1111/bph.16024

BibTeX
@article{Zhang2023,
  author = {Zhang, Zhirui and Wu, Wei and Jiao, Hao and Chen, Yuzhong and Ji, Xiaojun and Cao, Jing and Yin, Fangzhou and Yin, Wu},
  title = {Squalene epoxidase promotes hepatocellular carcinoma development by activating STRAP transcription and TGF‐β/SMAD signalling},
  journal = {British Journal of Pharmacology},
  year = {2023},
  volume = {180},
  number = {12},
  pages = {1562--1581},
  doi = {10.1111/bph.16024}
}
Start for free →